# Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Study · id `cardio:ct-nct04744571` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04744571](<https://clinicaltrials.gov/study/NCT04744571>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04744571

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04744571. Randomized; no masking; primary purpose treatment. Start 2021-02 (anticipated); primary completion 2022-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04744571, source copy `cardio:ctgov-nct04744571-2021-02-09`, retrieved 2026-10-26)
- Planned start: 2021-02 (anticipated) (ClinicalTrials.gov record NCT04744571, source copy `cardio:ctgov-nct04744571-2021-02-09`, retrieved 2026-10-26)
- Primary completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT04744571, source copy `cardio:ctgov-nct04744571-2021-02-09`, retrieved 2026-10-26)
- Completion: 2023-01 (anticipated) (ClinicalTrials.gov record NCT04744571, source copy `cardio:ctgov-nct04744571-2021-02-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04744571, source copy `cardio:ctgov-nct04744571-2021-02-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04744571-2021-02-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
- Condition: Coronary Artery Disease
- Condition: Coronary Occlusion
- Condition: Percutaneous Coronary Intervention
- Condition: Chronic Total Occlusion of Coronary Artery
- Condition: Drug-Eluting Stents
- Intervention (Drug): aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- Intervention (Device): coronary wires. or coronary balloons
- Intervention (Other): drug-coated balloon
- Intervention (Device): drug-eluting stent
- Lead sponsor: Beijing Anzhen Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)

## Provenance

Content hash: 24865be8c789f4a661b61a4a0d62babf50c696f5374a599add11e00ed66ee598
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
